Thursday, 23 September 2021


Luminex to acquire MilliporeSigma’s flow cytometry portfolio

21 October 2018 | News

The transaction is likely to complete by the end of this year.

Image credit- clpmag.com

Image credit- clpmag.com

Luminex has signed a definitive agreement to buy MilliporeSigma’s flow cytometry portfolio for $75 million.

This deal amount comprises around $69.9 million to be paid under a stock and asset purchase agreement and around $5.1million in committed inventory purchases.

The transaction is likely to complete by the end of this year and expected to contribute anywhere between $40 and $50 million in revenue to Luminex in 2019.

Luminex will be able to expand its current offering of flow-based detection systems, which is based on its innovative xMAP multiplexing technology. So far, over 15,000 xMAP systems have been sold across the world.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account